DOCSLIB.ORG

Bioprocess International CELL LINE DEVELOPMENT

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Bioprocess International CELL LINE DEVELOPMENT BioProcess International CELL LINE DEVELOPMENT September 2019 Introduction . .1 Reporting from the Frontiers of Cell Line Engineering at BPI Europe and BPI West FROM GENOME Cheryl Scott Creating New Cell Lines By Genome Editing . 10 Simplifying Cell-Based Assays and Improving EDITING TO MEDIA Production of Biomolecules Masahito Yamagata Streamlined Serum-Free Adaptation of ADAPTATION CHO-DG44 Cells . .14 Using a Novel Chemically Defined Medium N. Moroni, A. Di Nunzio, A. Perli, R. Puca, K. Hammett, G. Piras, J. Brooks, and L. Sibilio FEATURED REPORT Digital Edition Copyright Notice The content contained in this digital edition (“Digital Material”), as well as its selection and arrangement, is owned by Informa. and its affiliated companies, licensors, and suppliers, and is protected by their respective copyright, trademark and other proprietary rights. Upon payment of the subscription price, if applicable, you are hereby authorized to view, download, copy, and print Digital Material solely for your own personal, non-commercial use, provided that by doing any of the foregoing, you acknowledge that (i) you do not and will not acquire any ownership rights of any kind in the Digital Material or any portion thereof, (ii) you must preserve all copyright and other proprietary notices included in any downloaded Digital Material, and (iii) you must comply in all respects with the use restrictions set forth below and in the Informa Privacy Policy and the Informa Terms of Use (the “Use Restrictions”), each of which is hereby incorporated by reference. Any use not in accordance with, and any failure to comply fully with, the Use Restrictions is expressly prohibited by law, and may result in severe civil and criminal penalties. Violators will be prosecuted to the maximum possible extent. You may not modify, publish, license, transmit (including by way of email, facsimile or other electronic means), transfer, sell, reproduce (including by copying or posting on any network computer), create derivative works from, display, store, or in any way exploit, broadcast, disseminate or distribute, in any format or media of any kind, any of the Digital Material, in whole or in part, without the express prior written consent of Informa. To request content for commercial use or Informa’s approval of any other restricted activity described above, please contact the Reprints Department at (877) 652-5295. Without in any way limiting the foregoing, you may not use spiders, robots, data mining techniques or other automated techniques to catalog, download or otherwise reproduce, store or distribute any Digital Material. NEITHER Informa NOR ANY THIRD PARTY CONTENT PROVIDER OR THEIR AGENTS SHALL BE LIABLE FOR ANY ACT, DIRECT OR INDIRECT, INCIDENTAL, SPECIAL OR CONSEQUENTIAL DAMAGES ARISING OUT OF THE USE OF OR ACCESS TO ANY DIGITAL MATERIAL, AND/OR ANY INFORMATION CONTAINED THEREIN. CLD Platform Introduction Reporting from the Frontiers of Cell line Engineering at BPI Europe and BPI West Cheryl Scott very biomanufacturing process begins with transfection of recombinant genes into pools of cells — followed by a succession of E screenings from which will emerge (ideally) a single progenitor cell of the new production cell line. Cast aside will be those cells that do not uptake the correct genetic material, those incapable of thriving in bioprocess conditions, those that fail to produce recombinant protein at relevant levels, and those without demonstrated clonality and relative genetic stability. Over the past several years, advancing technologies for genetic engineering, screening, clone selection, analysis, and data management have HTTPS://STOCK.ADOBE.COM brought about a revolution in cell line development. Audiences at the BioProcess International (BPI) An efficient cell factory, Borth said, results from conferences have watched this field evolve as “a complex interplay of many genes and activities. presenters shared their insights and reported on their Productive cells reduce ‘unnecessary’ functions. experiences. This year’s BPI Europe and BPI West They are efficient in providing precursors and events continued in that vein with presentations on energy.” Although certain pathways do come up time technology platforms, clonality, cell line (genetic) and again, the precise genes getting regulated engineering, and development of biosimilars and differentially within those pathways will vary. other challenging product modalities. “Epigenetic regulation determines the transcriptome of each cell and cell type,” Borth The Track at BPI Europe explained. That includes different layers of The BPI Europe conference and exhibition in Vienna, regulation both for long-term “memory” and rapid Austria, this past April devoted an entire track to cell response to changing culture conditions. And this line engineering and development. Speakers came makes epigenetics the second major contributor from across the biopharmaceutical “ecosystem”: (after the genome itself) to phenotypic variation. She bioprocess suppliers, drug developers, and academia. said that the true secret to control of gene expression They discussed genetics, new technologies, and case will be to use epigenetics to determine phenotype studies from the frontiers of the industry. and behavior. “The future of phenotype control will Genomics and More: Nicole Borth (professor at require more detailed understanding of gene BOKU University and ACIB) focused on epigenetics of expression regulation. Manipulating expression of Chinese hamster ovary (CHO) cells in her talk, multiple genes simultaneously requires synthetic “Genome Scale Science for CHO.” She explained that biology and epigenetic control tools.” scientists had spent 20 years hunting for a single In “Engineering Complex Traits in the gene to boost process performance of mammalian Postgenomic Era of CHO Cell Line Development,” cell lines (whether overexpressed or knocked out/ Nathan Lewis (assistant professor in the departments down) by improving productivity, growth, and of pediatrics and bioengineering at the University of product quality all in one fell swoop. Unfortunately, California, San Diego) echoed Borth’s conclusions. she said, such a “miracle gene” is not likely to exist. “Many desirable traits require multiple gene edits,” Featured Report September 2019 17(9)i BioProcess International 1 Upcoming KNect365 Events stoichiometric gene expression. He identified four Pre-Conference Symposium on Cell Line Development categories of expression cassette design criteria: cell and Engineering at the BioProcess International productivity, quality of expressed protein products, Conference and Exhibition in Boston, MA, on design simplicity, and control and stability of protein 9 September 2019; https://lifesciences.knect365.com/ expression. bioprocessinternational/agenda/1# Focusing on design space, Brown described a Online Academy: Early Stage Upstream Process quality by design (QbD) approach to expression Development, five weeks starting 1 October 2019; https:// cassettes. Designers must answer three questions: lifesciences.knect365.com/early-stage-upstream-process- What can’t we control precisely (gene specificity)? development What rates will we keep constant (set points)? and Two-Day Course: Upstream Bioprocess Development in How will we achieve precise stoichiometries (control London, UK, on 26–27 November 2019; https://lifesciences. point)? Brown illustrated the testing phases that knect365.com/upstream-bioprocess-development follow those decisions, identifying the ultimate goal as a system that enables robust, user-defined Track on Cell Line Development and Upstream Processing manipulation of gene expression stoichiometry. at BioProcess International Asia in Kyoto, Japan, on 26–28 February 2020; https://lifesciences.knect365.com/ “Further engineering is required to achieve bpi-asia/ highly predictable, fine-tuned control,” he explained, “and to achieve the objective design criteria.” Cell Line Development and Engineering, colocated with Advancing Technologies: Anton Bauer (senior BioProcess International US West in Santa Clara, CA, on scientist at the Medical University of Vienna) 9–12 March 2020; https://lifesciences.knect365.com/ highlighted BESTcell technology from The Antibody cellline Lab in “The BEST of Both Worlds — Targeted Cell Line Development and Engineering Europe at Integration and Multiple Copies: How Can This Go BioProcess International Europe in Amsterdam, The Together for Improved Cell Line Development?” He Netherlands, on 28–30 April 2020; https://lifesciences. identified the challenge of developing highly knect365.com/bpieurope productive stable mammalian cell clones within just three weeks from transfection. he explained. “Pathway knowledge and large data Common methods for generation of stable sets can guide cell engineering.” mammalian cell lines include random integration of As an example, he highlighted the risk of virus classical plasmid constructs; including chromatin contamination of mammalian cell lines and cultures. modulators on those plasmids (for random Profiling virus-resistant cells points to regulators of integration of the plasmid constructs flanked by resistance. In a case study, knocking out “antirepressors” for chromatin modulation); and combinations of resistance repressors created virus- knock-in approaches (using highly active host-cell resistant cells. loci for transcription of a transgene). But Bauer Niall Barron (director of the National Institute for pointed out that silencing of the gene of interest
Load more

Recommended publications
  • Nanotechnology in Drug Delivery: the Need for More Cell Culture Based
    Kura et al. Chemistry Central Journal 2014, 8:46 http://journal.chemistrycentral.com/content/8/1/46 MINI REVIEW Open Access Nanotechnology in drug delivery: the need for more cell culture based studies in screening Aminu Umar Kura1, Sharida Fakurazi1,2*, Mohd Zobir Hussein3 and Palanisamy Arulselvan1 Abstract Advances in biomedical science are leading to upsurge synthesis of nanodelivery systems for drug delivery. The systems were characterized by controlled, targeted and sustained drug delivery ability. Humans are the target of these systems, hence, animals whose systems resembles humans were used to predict outcome. Thus, increasing costs in money and time, plus ethical concerns over animal usage. However, with consideration and planning in experimental conditions, in vitro pharmacological studies of the nanodelivery can mimic the in vivo system. This can function as a simple method to investigate the effect of such materials without endangering animals especially at screening phase. Keywords: In vitro, Animal studies, Nanodelivery system, Toxicity and bio distribution Introduction However, with changes and improvement in drug de- Nanodelivery system (NDS) is a branch of Nanomedicine livery via NDS comes a price (possible toxic effect), the characterized by controlled, targeted and sustained drug evaluation of which is important before any biological delivery ability, a limitation and drawback that is currently application can be introduce. In 2004, the term nanotoxi- limiting conventional drug delivery system especially city was coined; referring to the study of the potential in drug delivery to tight areas like the brain [1]. NDS, toxic impacts of nanoparticles on biological and ecological due to their small sizes usually below 100 nm and systems [5].
    [Show full text]
  • Food Produced Using Animal Cell Culture Technology (07/12/2018) Page 1
    Food Produced Using Animal Cell Culture Technology (07/12/2018) Page 1 U.S. FOOD & DRUG ADMINISTRATION OFFICE OF FOODS AND VETERINARY MEDICINE CENTER FOR FOOD SAFETY & APPLIED NUTRITION FDA Public Meeting: Foods Produced Using Animal Cell Culture Technology Docket No. FDA-2018-N-2155 Harvey W. Wiley Federal Building - Auditorium 5001 Campus Drive College Park, MD 20740 Thursday, July 12, 2018 Reported by: Natalia Thomas, Capital Reporting Company Food Produced Using Animal Cell Culture Technology (07/12/2018) Page 2 A P P E A R A N C E S Jessica Almy The Good Food Institute Kari Barrett Advisor for Strategic Communications and Public Engagement, Office of Food and Veterinary Medicine, FDA Danielle Beck National Cattlemen's Beef Association Dustin Boler, PhD American Meat Science Association Benjamina Bollag Higher Steaks Beth Briczinski, PhD National Milk Producers Federation Lou Cooperhouse BlueNalu Isha Datar Executive Director, New Harvest Jeremiah Fasano Consumer Safety Officer, Division of Biotechnology and GRAS Notice Review, Office of Food Additive Food Produced Using Animal Cell Culture Technology (07/12/2018) Page 3 A P P E A R A N C E S Safety, Center for Food Safety and Applied Nutrition, FDA Scott Gottlieb, MD Commissioner, FDA Michael Hansen, PhD Consumers Union Gregory Jaffe Director, Project on Biotechnology, Center for Science in the Public Interest William Jones, PhD Acting Director, Office of Food Safety, Center for Food Safety and Applied Nutrition, FDA Kate Krueger, PhD New Harvest Tiffany Lee, DVM North American Meat Institute Peter Licari Chief Technology Officer, JUST Susan Mayne, PhD Director, Center for Food Safety and Applied Nutrition, FDA Food Produced Using Animal Cell Culture Technology (07/12/2018) Page 4 A P P E A R A N C E S Paul McCright, PhD Biotrack Diagnostics, Inc.
    [Show full text]
  • Use of Cell Culture in Virology for Developing Countries in the South-East Asia Region © World Health Organization 2017
    USE OF CELL C USE OF CELL U LT U RE IN VIROLOGY FOR DE RE IN VIROLOGY V ELOPING C O U NTRIES IN THE NTRIES IN S O U TH- E AST USE OF CELL CULTURE A SIA IN VIROLOGY FOR R EGION ISBN: 978-92-9022-600-0 DEVELOPING COUNTRIES IN THE SOUTH-EAST ASIA REGION World Health House Indraprastha Estate, Mahatma Gandhi Marg, New Delhi-110002, India Website: www.searo.who.int USE OF CELL CULTURE IN VIROLOGY FOR DEVELOPING COUNTRIES IN THE SOUTH-EAST ASIA REGION © World Health Organization 2017 Some rights reserved. This work is available under the Creative Commons Attribution-NonCommercial- ShareAlike 3.0 IGO licence (CC BY-NC-SA 3.0 IGO; https://creativecommons.org/licenses/by-nc-sa/3.0/igo). Under the terms of this licence, you may copy, redistribute and adapt the work for non-commercial purposes, provided the work is appropriately cited, as indicated below. In any use of this work, there should be no suggestion that WHO endorses any specific organization, products or services. The use of the WHO logo is not permitted. If you adapt the work, then you must license your work under the same or equivalent Creative Commons licence. If you create a translation of this work, you should add the following disclaimer along with the suggested citation: “This translation was not created by the World Health Organization (WHO). WHO is not responsible for the content or accuracy of this translation. The original English edition shall be the binding and authentic edition.” Any mediation relating to disputes arising under the licence shall be conducted in accordance with the mediation rules of the World Intellectual Property Organization.
    [Show full text]
  • 68 Appendix A. Viral Isolation Protocol (For Cell Culture)
    Appendix A. Viral Isolation Protocol (for Cell Culture) Introduction The optimal method for determining specific etiology of an arbovirus infection requires isolation of the virus from a specimen obtained from the patient during the acute stage of the disease and the demonstration of a rise in titer of an antibody to the isolate during convalescence. For a number of reasons successful isolation of most arboviruses from specimens from patients is the exception, reasons being that the specimen to be examined is not collected soon enough, is not properly handled, or is not expeditiously transmitted to the virus laboratory for inoculation. The viremia for many arbovirus infections in humans, if detectable at any stage, ceases by the time of or soon after onset of symptoms-- a stage when antibody is often demonstrable. Because some circulating virus may be recoverable and the antibody may be absent, or present in low titer, the acute-phase blood specimen should be collected immediately upon suspicion of a viral etiology. Delay of an hour or so can compromise the chance of virus isolation; the allowable time depends upon the type of viruses involved. Certain arboviruses produce a viremia of sufficient magnitude and duration that the viruses can be isolated from blood during the acute phase of illness, e.g., 0 to 5 days after onset. Examples of these viruses include the agents of yellow fever, dengue, chikungunya, Venezuelan equine encephalitis (VEE), and sandfly, Ross River, and Oropouche fevers. The viremia in Colorado tick fever is unique because it can extend for weeks or months, and infection has been transmitted by transfusions.
    [Show full text]
  • Chapter 11: Virology
    CHAPTER 11 Virology Ken Peters USFWS – Bozeman Fish Health Center Bozeman, Montana NWFHS Laboratory Procedures Manual - Second Edition, June 2004 Chapter 11 - Page 1 I. Introduction Detection of aquatic animal viruses historically has been by growth and isolation on living cell cultures appropriately researched and chosen for the propagation of target viruses and species of host. Viral detection can also include immunological and nucleotide testing procedures. The determination of a testing procedure is a complex decision involving factors of cost, timeliness, sensitivity, specificity, efficiency, and available host tissues and technology. For the purposes of the Wild Fish Health Survey, the USFWS has chosen the use of cell culture for initial screening and corroboration of test results using appropriate nucleotide primers of specific viral pathogens in polymerase chain reaction (PCR) tests. Other corroborative tests may also be utilized, including serum neutralization, indirect fluorescent antibody techniques, biotinylated DNA probes, and immuno-dot blot tests (see Chapter 12 - Corroborative Testing of Viral Isolates). The following sections describe the procedures and methods for virology using standard cell culture techniques. Definitions: Several terms are used routinely in virology and throughout this section. A full Glossary of terms can be found in Appendix A. Media Formulations: See Appendix B: Media Used in Tissue Culture and Virology. II. Selection of Appropriate Cell Lines All viral testing will utilize cell lines traceable to cell lines from the American Type Culture Collection (ATCC) when available. At the minimum, cell lines will be tested annually for viral sensitivity and mycoplasma infection: see section VI. Quality Control in Tissue Culture, in Chapter 10 -Tissue Culture of Fish Cell Lines.
    [Show full text]
  • Introduction to Mammalian Cell Culture
    Workshop Training Series Biomedical and Obesity Research Core Nebraska Center for the Prevention of Obesity Diseases through Dietary Molecules Introduction to Mammalian Cell Culture April 9, 2019 Yongjun Wang Ph.D. Director of Biomedical and Obesity Research Core Nebraska Center for the Prevention of Obesity Diseases through Dietary Molecules What Is Cell Culture Cell culture is the process by which cells are grown in controlled conditions outside of their native environment. Timeline: key milestone in cell cultures History of Cell Culture http://dx.doi.org/10.5772/66905 Primary vs Cell line Primary cells Cell lines Lifespan and division capacity Limited Indefinite Isolated in the lab or bought from Source Bought from commercial provider commercial provider Care and maintenance Complex and difficult Easy to maintain or proliferate Chromosomal aberration Minimal Several Retention of functional markers and Yes Not always signaling pathways Functional study, diagnosis, Drug development, vaccine and protein Application Gene therapy, et al. production, et al. Three Types of Cells Epithelial-like cells Fibroblast-like cells Lymphoblast-like cells Cell differentiation 3T3L1 cells C212 cells Cell Culture Vessels • Most adherent cells require attachment to proliferate • Polystyrene are treated to become hydrophilic and negatively charged once medium is added • Coating with basic synthetic polymers • Poly-L-lysine • Coating with matrix proteins • Collagen, laminin, gelatin, fibronectin Class II Biological Safety Cabinet The Class II Biological Safety
    [Show full text]
  • Guide to Biotechnology 2008
    guide to biotechnology 2008 research & development health bioethics innovate industrial & environmental food & agriculture biodefense Biotechnology Industry Organization 1201 Maryland Avenue, SW imagine Suite 900 Washington, DC 20024 intellectual property 202.962.9200 (phone) 202.488.6301 (fax) bio.org inform bio.org The Guide to Biotechnology is compiled by the Biotechnology Industry Organization (BIO) Editors Roxanna Guilford-Blake Debbie Strickland Contributors BIO Staff table of Contents Biotechnology: A Collection of Technologies 1 Regenerative Medicine ................................................. 36 What Is Biotechnology? .................................................. 1 Vaccines ....................................................................... 37 Cells and Biological Molecules ........................................ 1 Plant-Made Pharmaceuticals ........................................ 37 Therapeutic Development Overview .............................. 38 Biotechnology Industry Facts 2 Market Capitalization, 1994–2006 .................................. 3 Agricultural Production Applications 41 U.S. Biotech Industry Statistics: 1995–2006 ................... 3 Crop Biotechnology ...................................................... 41 U.S. Public Companies by Region, 2006 ........................ 4 Forest Biotechnology .................................................... 44 Total Financing, 1998–2007 (in billions of U.S. dollars) .... 4 Animal Biotechnology ................................................... 45 Biotech
    [Show full text]
  • What Is Cell Culture? Cell Culture Refers to the Removal of Cells from an Animal Or Plant and Their Subsequent Growth in a Favorable Artificial Environment
    What is Cell Culture? Cell culture refers to the removal of cells from an animal or plant and their subsequent growth in a favorable artificial environment. The cells may be removed from the tissue directly and disaggregated by enzymatic or mechanical means before cultivation, or they may be derived from a cell line or cell strain that has already been established. It is widely used for growing viruses. Tissues are dissociated into the component cells by the action of enzyme and mechanical shaking. The cells are washed ,counted and suspended in a growth medium. The growth medium conists of essential amino acids,glucose,vitamins , salts and a buffer.Antibiotics are added to prevent bacterial contamination . the cell suspension is put into bottles , tubes and pertidishes. The cell adhere to the glass or plastics surface , divide and form a confluent monplayer sheet within a week . Cell culture is further classified on the basis of origin,chromosomal characters and the number of generations through which they can be maintained . It is of three types- primary cell culture,diploid cell strain and continuous cell lines. 1. Primary cell culture 2. Diploid cell strain 3. Continuous cell culture Primary cell culture 1. They are normal cells freshly taken from the body and cultured. They are capable of only limited growth in culture. They cannot be maintained in serial culture example :- monkey kidney, human embryo kidnry and chick embryo cell culture . 2. Primary Cultures Primary cultures are derived directly from excised, normal animal tissue and cultures either as an explant culture or following dissociation into a single cell suspension by enzyme digestion.
    [Show full text]
  • Atcc Animal Cell Culture Guide
    ® ATCC ANIMAL CELL CULTURE GUIDE tips and techniques for continuous cell lines THE ESSENTIALS OF LIFE SCIENCE RESEARCH GLOBALLY DELIVERED™ Table of Contents This guide contains general technical information for working with animal cells in culture, including media, subculturing, cryopreservation and contamination. A more comprehensive reference on animal cell culture can be found in Culture of Animal Cells: A Manual of Basic Technique, 5th edition, by R. Ian Freshney (24). Getting Started with an ATCC Cell Line ............1 Culture Vessels and Surfaces ..................................20 Product Sheet .............................................................1 Vessels ........................................................................20 Preparation of Medium ...........................................1 Surface Coatings and Feeder Cells ...................22 Initiating Frozen Cultures .......................................1 Processing Flask Cultures .......................................1 Cryopreservation ..............................................................24 Overview ...................................................................24 Cell Growth and Propagation ...................................4 Freeze Medium .......................................................24 Passage Number and Population Doubling Equipment ................................................................25 Level ...............................................................................4 Liquid Nitrogen Freezer Storage.......................26
    [Show full text]
  • Virology Techniques
    Chapter 5 - Lesson 4 Virology Techniques Introduction Virology is a field within microbiology that encom- passes the study of viruses and the diseases they cause. In the laboratory, viruses have served as useful tools to better understand cellular mechanisms. The purpose of this lesson is to provide a general overview of laboratory techniques used in the identification and study of viruses. A Brief History In the late 19th century the independent work of Dimitri Ivanofsky and Martinus Beijerinck marked the begin- This electron micrograph depicts an influenza virus ning of the field of virology. They showed that the agent particle or virion. CDC. responsible for causing a serious disease in tobacco plants, tobacco mosaic virus, was able to pass through filters known to retain bacteria and the filtrate was able to cause disease in new plants. In 1898, Friedrich Loef- fler and Paul Frosch applied the filtration criteria to a disease in cattle known as foot and mouth disease. The filtration criteria remained the standard method used to classify an agent as a virus for nearly 40 years until chemical and physical studies revealed the structural basis of viruses. These attributes have become the ba- sis of many techniques used in the field today. Background All organisms are affected by viruses because viruses are capable of infecting and causing disease in all liv- ing species. Viruses affect plants, humans, and ani- mals as well as bacteria. A virus that infects bacteria is known as a bacteriophage and is considered the Bacteriophage. CDC. Chapter 5 - Human Health: Real Life Example (Influenza) 1 most abundant biological entity on the planet.
    [Show full text]
  • CRISPR/Cas9 Genetic Modification of CYP3A5 *3 in Huh-7 Human Hepatocyte Cell Line Leads to Cell Lines with Increased Midazolam and Tacrolimus Metabolism S
    Supplemental material to this article can be found at: http://dmd.aspetjournals.org/content/suppl/2017/05/22/dmd.117.076307.DC1 1521-009X/45/8/957–965$25.00 https://doi.org/10.1124/dmd.117.076307 DRUG METABOLISM AND DISPOSITION Drug Metab Dispos 45:957–965, August 2017 Copyright ª 2017 by The American Society for Pharmacology and Experimental Therapeutics CRISPR/Cas9 Genetic Modification of CYP3A5 *3 in HuH-7 Human Hepatocyte Cell Line Leads to Cell Lines with Increased Midazolam and Tacrolimus Metabolism s Casey R. Dorr, Rory P. Remmel, Amutha Muthusamy, James Fisher, Branden S. Moriarity, Kazuto Yasuda, Baolin Wu, Weihua Guan, Erin G. Schuetz, William S. Oetting, Pamala A. Jacobson, and Ajay K. Israni Molecular Epidemiology Laboratory, Minneapolis Medical Research Foundation, Minneapolis, Minnesota Received April 13, 2017; accepted May 18, 2017 ABSTRACT Downloaded from Clustered regularly interspaced short palindromic repeats (CRISPR)/ assays, HuH-7 had less tacrolimus (all P < 0.05) or midazolam Cas9 engineering of the CYP3A5 *3 locus (rs776746) in human liver (MDZ) (all P < 0.005) disappearance than all engineered cell lines. cell line HuH-7 (CYP3A5 *3/*3)hasledtothreeCYP3A5 *1 cell lines by HuH-7 had less 1-OH MDZ (all P < 0.0005) or 4-OH (all P < 0.005) deletion of the exon 3B splice junction or point mutation. Cell lines production in metabolism assays than all bioengineered cell CYP3A5 *1/*3 sd (single deletion), CYP3A5 *1/*1 dd (double deletion), lines. We confirmed CYP3A5 metabolic activity with the CYP3A4 or CYP3A5 *1/*3 pm (point mutation) expressed the CYP3A5 *1 mRNA selective inhibitor CYP3CIDE.
    [Show full text]
  • Biochemical Methods in Cell Culture and Virology by R
    BOOK REVIEWS 221 It will be of special value to practising clinical microbiologists, pathologists and medical laboratory technologists ; it will be welcomed by senior students of medical microbiology; and it can be recommended to clinical colleagues who seek a range of tutorials on the patho- genic anaerobes. J. G. COLLEE Biochemical methods in cell culture and virology By R. J. KUCHLER.1977. Chichester, Sussex: John Wiley & Sons Ltd. Pp. ix and 331. E22.50. The title of this book accurately describes its contents. It is a compendium of materials and methods directed principally at investigators studying biochemical aspects of virology. The book is in three sections dealing with cell culture, virology and macromolecular analysis. The first part, on cell culture, consists of an orthodox treatment covering a selection of procedures as described in other well-known text books. The second section comprises two chapters, one on isolation and identification of animal viruses and the other on virus growth and purification. These deal entirely with animal virology; none of the material relates to bacterial or plant viruses. The methods described vary from straightforward isolation and diagnostic procedures to methods for the production of conditional and lethal mutants and for the purification of variants. The third section, on macromolecular analysis, has three chapters headed Deoxyribonucleic Acid, Ribonucleic Acid and Protein. The methods described include simple preparation procedures, electronmicroscopy, gradient centrifugation and electrophoresis, and extend to oligonucleotide mapping and peptide mapping procedures. The author’s style is terse. Indeed, this is absolutely essential to cover the range of procedures in just over 300 pages.
    [Show full text]